Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| Lēmumu analītiskā modelēšana veselības ekonomikā× | Gada dzīvības kvalitātes koriģētais gads (QALY)× | |
|---|---|---|
| Nozare | Veselības ekonomika | Veselības ekonomika |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1975 | 1985 |
| Autors≠ | Pauker & Kassirer (medical decision analysis, Massachusetts General Hospital) | Alan Williams (Health Economics Research Centre, Oxford University) |
| Tips | Method | Method |
| Pirmavots≠ | Pauker, S. G., & Kassirer, J. P. (1975). Therapeutic Decision Making: A Cost-Benefit Analysis. New England Journal of Medicine, 293(5), 229-234. DOI ↗ | Kind, P. (1989). The EuroQol instrument: an index of health-related quality of life. In B. Teeling Smith (Ed.), Measuring health: a practical approach. Chichester: Wiley. link ↗ |
| Citi nosaukumi≠ | decision analysis, decision tree, decision model, health economic model | QALY, health utility measure |
| Saistītās | 5 | 5 |
| Kopsavilkums≠ | Decision analytic modeling is a systematic framework for comparing health interventions by integrating evidence on probabilities, outcomes, costs, and patient preferences into a quantitative model. Developed by Pauker and Kassirer in 1975, decision analysis structures clinical uncertainty and economic trade-offs, enabling transparent comparison of treatment options and identification of optimal strategies. Used in health technology assessment, clinical practice guideline development, and resource allocation decisions. | A QALY measures health benefit as utility weight (0 = death, 1 = perfect health) multiplied by time lived. Developed by Alan Williams in 1985, QALYs enable comparison of disparate health interventions on a common metric. Used globally by health technology assessment bodies—NICE (UK), HAS (France), CADTH (Canada), WHO—to decide which treatments deserve public funding. |
| ScholarGateDatu kopa ↗ |
|
|